Last Updated: June 22, 2026

SULFACETAMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sulfacetamide patents expire, and when can generic versions of Sulfacetamide launch?

Sulfacetamide is a drug marketed by Fougera Pharms, Padagis Us, Sun Pharma Canada, Alcon Pharms Ltd, Bausch And Lomb, Chartwell Rx, Epic Pharma Llc, Pharmafair, Pharmobedient, and Genus. and is included in twelve NDAs.

The generic ingredient in SULFACETAMIDE is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SULFACETAMIDE?
  • What are the global sales for SULFACETAMIDE?
  • What is Average Wholesale Price for SULFACETAMIDE?
Summary for SULFACETAMIDE
US Patents:0
Applicants:10
NDAs:12
Drug Prices: Drug price information for SULFACETAMIDE
DailyMed Link:SULFACETAMIDE at DailyMed

US Patents and Regulatory Information for SULFACETAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 077015-001 Nov 17, 2006 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 089560-001 Oct 18, 1988 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Padagis Us SULFACETAMIDE SODIUM sulfacetamide sodium OINTMENT;OPHTHALMIC 080029-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Genus SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 073630-001 May 27, 1993 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Epic Pharma Llc SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 040216-001 May 25, 1999 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.